SBC Medical Group (SBC) Stock: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$5.28
-0.41 (-7.21%)
âŧ
5d:
+2.33%
30d:
+11.16%
90d:
+65.52%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
19d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SBC is fairly priced but lacks strong directional signals. At 7.6% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SBC is fairly priced but lacks strong directional signals. At 7.6% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.06
Based on 10.7% avg growth
INTRINSIC VALUE TODAY
$4.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $5.28, which is considered slightly high relative to its 30-day fair value range of $4.83 to $5.42. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.8) compared to its historical average (7.9). At these levels, the market is pricing in 7.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SBC is in a strong uptrend. Immediate support is located at $5.11, while resistance sits at $5.79. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: SBC scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+65.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBC is in a strong uptrend. Immediate support is located at $5.11, while resistance sits at $5.79. Short-term momentum is weak, with the stock down 7.2% recently.
Market Sentiment: SBC scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.75 (+65.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.83 -
$5.42
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.1%
All Signals
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.2%)
- BULLISH: Trading 65.7% below Wall St target ($8.75)
- NEUTRAL: PE elevated vs history but 7.6% growth expectation is conservative given 339% recent growth
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.83 -
$5.42
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$5.11
Resistance Level
$5.79
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.78
Wall Street Target
$8.75
(+65.7%)
Revenue Growth (YoY)
13.4%
Earnings Growth (YoY)
338.9%
Profit Margin
28.0%
Valuation Premium vs History
+7.6% premium
PE vs Historical
9.8 vs 7.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.6%
(market-implied from PE analysis)
1-Year Target
$5.68
(+8%)
2-Year Target
$6.11
(+16%)
3-Year Target
$6.58
(+25%)
3-Yr Target (if PE normalizes)
(PE: 10â8)
PE COMPRESSION
$5.31
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 17.4%)
$17.35
(+229%)
Base:
(SPY PE: 9.8, Growth: 17.4%)
$8.54
(+62%)
Bear:
(PE: 7.9, Growth: 17.4%)
$6.90
(+31%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.85 | Current EPS (TTM): $0.48
Bull Case
$7.04
(+33%)
Analyst growth 12.5%, PE expands to 13.0
Base Case
$6.40
(+21%)
Market implied 12.5%, PE stable at 11.9
Bear Case
$3.87
(-27%)
Severe decline -20.0%, PE contracts to 10.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 24, 2026 5:08 PM ET
Data refreshes hourly during market hours. Next update: 6:08 PM
Data refreshes hourly during market hours. Next update: 6:08 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
STRONG BUY
24 analysts |
$196 | 42 HOLD |
|
VRSK
Verisk Analytics Inc |
BUY
19 analysts |
$228 | 36 SELL |
|
HURN
Huron Consulting Group IâĻ |
STRONG BUY
5 analysts |
$191 | 43 HOLD |
|
ICFI
ICF International Inc |
STRONG BUY
5 analysts |
$107 | 48 HOLD |
|
BAH
Booz Allen Hamilton HoldâĻ |
SELL
15 analysts |
$84 | 47 HOLD |
